Atlas Trials

Immunological Basis for Mepolizumab Activity in COPD

Clinical trial NCT05320939 · UNKNOWN

Trial details

NCT number
NCT05320939
Sponsor
Temple University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COPD
Start date
2023-04-01
Primary completion
2024-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.